Children’s Benadryl Recalled for a Second Time
Johnson & Johnson’s McNeil Consumer Healthcare is recalling about 4 million units of Children’s BENADRYL® Allergy FASTMELT® Tablets, in cherry and grape flavors, along with all lots of Junior Strength MOTRIN® tablets. The recall is retail and wholesale only, and the company maintains that consumers can still use the medications.
In May, McNeil recalled more than 40 children’s medicines, including Infant Tylenol, Children’s Tylenol, Infant Motrin, Children’s Motrin and Children’s Benadryl. The medicines were said to contain more active ingredients than listed on the
bottle. Customers were urged to throw away the medicines without using them.
The current recall occurred after a review showed “insufficiencies in the development of the manufacturing process,” according to a company press release. The press release also said that customers can continue to use the products, as this is a “wholesale and retail recall.”
McNeil’s Comprehensive Action Plan uncovered the supposed flaws in the manufacturing process for the current recall. The company believes at this time that there is no sign that the affected products do not meet quality standards, and is conducting the recall as a cautionary measure.